Titan Pharmaceuticals Files 8-K on Shareholder Votes & Financials
| Field | Detail |
|---|---|
| Company | Titan Pharmaceuticals Inc |
| Form Type | 8-K |
| Filed Date | Jun 18, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-action, financial-reporting
TL;DR
Titan Pharma filed an 8-K on June 18th covering shareholder votes and financials as of June 16th.
AI Summary
Titan Pharmaceuticals, Inc. filed an 8-K on June 18, 2025, reporting on matters submitted to a vote of security holders and financial statements. The filing covers events up to June 16, 2025. The company is incorporated in Delaware and its principal executive offices are located in New York.
Why It Matters
This 8-K filing provides updates on important corporate actions and financial reporting for Titan Pharmaceuticals, which could impact investor decisions.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of corporate events and financial information, not indicating immediate operational or financial distress.
Key Players & Entities
- TITAN PHARMACEUTICALS INC (company) — Registrant
- June 16, 2025 (date) — Date of earliest event reported
- June 18, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of incorporation
- 10 East 53rd St. , Suite 3001 , New York , NY 10022 (address) — Principal executive offices
- (786) 769-7512 (phone_number) — Registrant's telephone number
FAQ
What specific matters were submitted to a vote of security holders?
The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the provided text excerpt.
What is the exact date of the report?
The exact date of the report is June 18, 2025.
When was the earliest event reported?
The earliest event reported was on June 16, 2025.
Where are Titan Pharmaceuticals, Inc.'s principal executive offices located?
Titan Pharmaceuticals, Inc.'s principal executive offices are located at 10 East 53rd St., Suite 3001, New York, NY 10022.
What is the company's telephone number?
The company's telephone number is (786) 769-7512.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 18, 2025 regarding TITAN PHARMACEUTICALS INC.